27548 Investors following Biocon. Share this News with them.
0
Like this story, share it with millions of investors on M3
Biocon Q1 PAT seen up at Rs 66.5 cr: Motilal Oswal
Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Biocon's June quarter sales are expected to go up by 82.2% to Rs 480.7 crore on YoY basis.
Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Biocon 's June quarter sales are expected to go up by 82.2% to Rs 480.7 crore on YoY basis.
The company's PAT (profit after tax) is expected to go up by 343.3% to Rs 66.5 crore on YoY basis.